APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Blood Coagulants

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Blood Coagulants Market Analysis and Forecast 2026-2032

Report ID 173971580219 December 2025191 pages

Choose your research edition.

Industry ResearchBlood Coagulants Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Blood Coagulants Industry Growth and Trends Forecast to 203292 pages · $3,450 USDMarket StructureGlobal Blood Coagulants Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Blood Coagulants Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Blood Coagulants Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Blood Coagulants market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Blood Coagulants is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Blood Coagulants is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Blood Coagulants is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Blood Coagulants is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Blood Coagulants include Takeda, Novo Nordisk, Pfizer, Bayer, SOBI, Octapharma and CSL, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Blood Coagulants, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Blood Coagulants, also provides the sales of main regions and countries. Of the upcoming market potential for Blood Coagulants, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Blood Coagulants sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Blood Coagulants market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Blood Coagulants sales, projected growth trends, production technology, application and end-user industry.

Blood Coagulants Segment by Company

Takeda

Novo Nordisk

Pfizer

Bayer

SOBI

Octapharma

CSL

Blood Coagulants Segment by Type

Recombinant Coagulation Factor

Plasma Coagulation Factor

Blood Coagulants Segment by Application

Hospital

Pharmacy

Other

Blood Coagulants Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Blood Coagulants market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Blood Coagulants and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Blood Coagulants.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Blood Coagulants in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Blood Coagulants manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Blood Coagulants sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Blood Coagulants Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Recombinant Coagulation Factor Major Manufacturers Table 3. Plasma Coagulation Factor Major Manufacturers Table 4. Global Blood Coagulants Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospital Major Manufacturers Table 6. Pharmacy Major Manufacturers Table 7. Other Major Manufacturers Table 8. Blood Coagulants Industry Trends Table 9. Blood Coagulants Industry Drivers Table 10. Blood Coagulants Industry Opportunities and Challenges Table 11. Blood Coagulants Industry Restraints Table 12. Global Blood Coagulants Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Blood Coagulants Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Blood Coagulants Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Blood Coagulants Revenue Market Share by Region (2021-2026) Table 16. Global Blood Coagulants Revenue Market Share by Region (2027-2032) Table 17. Global Blood Coagulants Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 18. Global Blood Coagulants Sales by Region (2021-2026) & (K Units) Table 19. Global Blood Coagulants Sales by Region (2027-2032) & (K Units) Table 20. Global Blood Coagulants Sales Market Share by Region (2021-2026) Table 21. Global Blood Coagulants Sales Market Share by Region (2027-2032) Table 22. Global Blood Coagulants Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Blood Coagulants Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Blood Coagulants Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Blood Coagulants Sales Market Share by Manufacturers (2021-2026) Table 26. Global Blood Coagulants Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 27. Global Blood Coagulants Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Blood Coagulants Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Blood Coagulants Manufacturers, Product Type & Application Table 30. Global Blood Coagulants Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Blood Coagulants by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Blood Coagulants Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Blood Coagulants Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Blood Coagulants Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Blood Coagulants Revenue Market Share by Type (2021-2026) Table 37. Global Blood Coagulants Revenue Market Share by Type (2027-2032) Table 38. Global Blood Coagulants Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 39. Global Blood Coagulants Sales by Type (2021-2026) & (K Units) Table 40. Global Blood Coagulants Sales by Type (2027-2032) & (K Units) Table 41. Global Blood Coagulants Sales Market Share by Type (2021-2026) Table 42. Global Blood Coagulants Sales Market Share by Type (2027-2032) Table 43. Global Blood Coagulants Price by Type (2021-2026) & (US$/Unit) Table 44. Global Blood Coagulants Price by Type (2027-2032) & (US$/Unit) Table 45. Global Blood Coagulants Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Blood Coagulants Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Blood Coagulants Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Blood Coagulants Revenue Market Share by Application (2021-2026) Table 49. Global Blood Coagulants Revenue Market Share by Application (2027-2032) Table 50. Global Blood Coagulants Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 51. Global Blood Coagulants Sales by Application (2021-2026) & (K Units) Table 52. Global Blood Coagulants Sales by Application (2027-2032) & (K Units) Table 53. Global Blood Coagulants Sales Market Share by Application (2021-2026) Table 54. Global Blood Coagulants Sales Market Share by Application (2027-2032) Table 55. Global Blood Coagulants Price by Application (2021-2026) & (US$/Unit) Table 56. Global Blood Coagulants Price by Application (2027-2032) & (US$/Unit) Table 57. Takeda Company Information Table 58. Takeda Business Overview Table 59. Takeda Blood Coagulants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 60. Takeda Blood Coagulants Product Portfolio Table 61. Takeda Recent Development Table 62. Novo Nordisk Company Information Table 63. Novo Nordisk Business Overview Table 64. Novo Nordisk Blood Coagulants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 65. Novo Nordisk Blood Coagulants Product Portfolio Table 66. Novo Nordisk Recent Development Table 67. Pfizer Company Information Table 68. Pfizer Business Overview Table 69. Pfizer Blood Coagulants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. Pfizer Blood Coagulants Product Portfolio Table 71. Pfizer Recent Development Table 72. Bayer Company Information Table 73. Bayer Business Overview Table 74. Bayer Blood Coagulants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Bayer Blood Coagulants Product Portfolio Table 76. Bayer Recent Development Table 77. SOBI Company Information Table 78. SOBI Business Overview Table 79. SOBI Blood Coagulants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. SOBI Blood Coagulants Product Portfolio Table 81. SOBI Recent Development Table 82. Octapharma Company Information Table 83. Octapharma Business Overview Table 84. Octapharma Blood Coagulants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Octapharma Blood Coagulants Product Portfolio Table 86. Octapharma Recent Development Table 87. CSL Company Information Table 88. CSL Business Overview Table 89. CSL Blood Coagulants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. CSL Blood Coagulants Product Portfolio Table 91. CSL Recent Development Table 92. North America Blood Coagulants Revenue by Type (2021-2026) & (US$ Million) Table 93. North America Blood Coagulants Revenue by Type (2027-2032) & (US$ Million) Table 94. North America Blood Coagulants Sales by Type (2021-2026) & (K Units) Table 95. North America Blood Coagulants Sales by Type (2027-2032) & (K Units) Table 96. North America Blood Coagulants Sales Price by Type (2021-2026) & (US$/Unit) Table 97. North America Blood Coagulants Sales Price by Type (2027-2032) & (US$/Unit) Table 98. North America Blood Coagulants Revenue by Application (2021-2026) & (US$ Million) Table 99. North America Blood Coagulants Revenue by Application (2027-2032) & (US$ Million) Table 100. North America Blood Coagulants Sales by Application (2021-2026) & (K Units) Table 101. North America Blood Coagulants Sales by Application (2027-2032) & (K Units) Table 102. North America Blood Coagulants Sales Price by Application (2021-2026) & (US$/Unit) Table 103. North America Blood Coagulants Sales Price by Application (2027-2032) & (US$/Unit) Table 104. North America Blood Coagulants Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 105. North America Blood Coagulants Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 106. North America Blood Coagulants Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 107. North America Blood Coagulants Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 108. North America Blood Coagulants Sales by Country (2021-2026) & (K Units) Table 109. North America Blood Coagulants Sales by Country (2027-2032) & (K Units) Table 110. North America Blood Coagulants Sales Price by Country (2021-2026) & (US$/Unit) Table 111. North America Blood Coagulants Sales Price by Country (2027-2032) & (US$/Unit) Table 112. United States Blood Coagulants Revenue (2021-2032) & (US$ Million) Table 113. Canada Blood Coagulants Revenue (2021-2032) & (US$ Million) Table 114. Europe Blood Coagulants Revenue by Type (2021-2026) & (US$ Million) Table 115. Europe Blood Coagulants Revenue by Type (2027-2032) & (US$ Million) Table 116. Europe Blood Coagulants Sales by Type (2021-2026) & (K Units) Table 117. Europe Blood Coagulants Sales by Type (2027-2032) & (K Units) Table 118. Europe Blood Coagulants Sales Price by Type (2021-2026) & (US$/Unit) Table 119. Europe Blood Coagulants Sales Price by Type (2027-2032) & (US$/Unit) Table 120. Europe Blood Coagulants Revenue by Application (2021-2026) & (US$ Million) Table 121. Europe Blood Coagulants Revenue by Application (2027-2032) & (US$ Million) Table 122. Europe Blood Coagulants Sales by Application (2021-2026) & (K Units) Table 123. Europe Blood Coagulants Sales by Application (2027-2032) & (K Units) Table 124. Europe Blood Coagulants Sales Price by Application (2021-2026) & (US$/Unit) Table 125. Europe Blood Coagulants Sales Price by Application (2027-2032) & (US$/Unit) Table 126. Europe Blood Coagulants Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 127. Europe Blood Coagulants Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 128. Europe Blood Coagulants Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 129. Europe Blood Coagulants Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 130. Europe Blood Coagulants Sales by Country (2021-2026) & (K Units) Table 131. Europe Blood Coagulants Sales by Country (2027-2032) & (K Units) Table 132. Europe Blood Coagulants Sales Price by Country (2021-2026) & (US$/Unit) Table 133. Europe Blood Coagulants Sales Price by Country (2027-2032) & (US$/Unit) Table 134. Germany Blood Coagulants Revenue (2021-2032) & (US$ Million) Table 135. France Blood Coagulants Revenue (2021-2032) & (US$ Million) Table 136. U.K. Blood Coagulants Revenue (2021-2032) & (US$ Million) Table 137. Italy Blood Coagulants Revenue (2021-2032) & (US$ Million) Table 138. Netherlands Blood Coagulants Revenue (2021-2032) & (US$ Million) Table 139. Nordic Countries Blood Coagulants Revenue (2021-2032) & (US$ Million) Table 140. China Blood Coagulants Revenue by Type (2021-2026) & (US$ Million) Table 141. China Blood Coagulants Revenue by Type (2027-2032) & (US$ Million) Table 142. China Blood Coagulants Sales by Type (2021-2026) & (K Units) Table 143. China Blood Coagulants Sales by Type (2027-2032) & (K Units) Table 144. China Blood Coagulants Sales Price by Type (2021-2026) & (US$/Unit) Table 145. China Blood Coagulants Sales Price by Type (2027-2032) & (US$/Unit) Table 146. China Blood Coagulants Revenue by Application (2021-2026) & (US$ Million) Table 147. China Blood Coagulants Revenue by Application (2027-2032) & (US$ Million) Table 148. China Blood Coagulants Sales by Application (2021-2026) & (K Units) Table 149. China Blood Coagulants Sales by Application (2027-2032) & (K Units) Table 150. China Blood Coagulants Sales Price by Application (2021-2026) & (US$/Unit) Table 151. China Blood Coagulants Sales Price by Application (2027-2032) & (US$/Unit) Table 152. Asia Blood Coagulants Revenue by Type (2021-2026) & (US$ Million) Table 153. Asia Blood Coagulants Revenue by Type (2027-2032) & (US$ Million) Table 154. Asia Blood Coagulants Sales by Type (2021-2026) & (K Units) Table 155. Asia Blood Coagulants Sales by Type (2027-2032) & (K Units) Table 156. Asia Blood Coagulants Sales Price by Type (2021-2026) & (US$/Unit) Table 157. Asia Blood Coagulants Sales Price by Type (2027-2032) & (US$/Unit) Table 158. Asia Blood Coagulants Revenue by Application (2021-2026) & (US$ Million) Table 159. Asia Blood Coagulants Revenue by Application (2027-2032) & (US$ Million) Table 160. Asia Blood Coagulants Sales by Application (2021-2026) & (K Units) Table 161. Asia Blood Coagulants Sales by Application (2027-2032) & (K Units) Table 162. Asia Blood Coagulants Sales Price by Application (2021-2026) & (US$/Unit) Table 163. Asia Blood Coagulants Sales Price by Application (2027-2032) & (US$/Unit) Table 164. Asia Blood Coagulants Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 165. Asia Blood Coagulants Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 166. Asia Blood Coagulants Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 167. Asia Blood Coagulants Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 168. Asia Blood Coagulants Sales by Country (2021-2026) & (K Units) Table 169. Asia Blood Coagulants Sales by Country (2027-2032) & (K Units) Table 170. Asia Blood Coagulants Sales Price by Country (2021-2026) & (US$/Unit) Table 171. Asia Blood Coagulants Sales Price by Country (2027-2032) & (US$/Unit) Table 172. Japan Blood Coagulants Revenue (2021-2032) & (US$ Million) Table 173. South Korea Blood Coagulants Revenue (2021-2032) & (US$ Million) Table 174. India Blood Coagulants Revenue (2021-2032) & (US$ Million) Table 175. Australia Blood Coagulants Revenue (2021-2032) & (US$ Million) Table 176. China Taiwan Blood Coagulants Revenue (2021-2032) & (US$ Million) Table 177. Southeast Asia Blood Coagulants Revenue (2021-2032) & (US$ Million) Table 178. SAMEA Blood Coagulants Revenue by Type (2021-2026) & (US$ Million) Table 179. SAMEA Blood Coagulants Revenue by Type (2027-2032) & (US$ Million) Table 180. SAMEA Blood Coagulants Sales by Type (2021-2026) & (K Units) Table 181. SAMEA Blood Coagulants Sales by Type (2027-2032) & (K Units) Table 182. SAMEA Blood Coagulants Sales Price by Type (2021-2026) & (US$/Unit) Table 183. SAMEA Blood Coagulants Sales Price by Type (2027-2032) & (US$/Unit) Table 184. SAMEA Blood Coagulants Revenue by Application (2021-2026) & (US$ Million) Table 185. SAMEA Blood Coagulants Revenue by Application (2027-2032) & (US$ Million) Table 186. SAMEA Blood Coagulants Sales by Application (2021-2026) & (K Units) Table 187. SAMEA Blood Coagulants Sales by Application (2027-2032) & (K Units) Table 188. SAMEA Blood Coagulants Sales Price by Application (2021-2026) & (US$/Unit) Table 189. SAMEA Blood Coagulants Sales Price by Application (2027-2032) & (US$/Unit) Table 190. SAMEA Blood Coagulants Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 191. SAMEA Blood Coagulants Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 192. SAMEA Blood Coagulants Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 193. SAMEA Blood Coagulants Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 194. SAMEA Blood Coagulants Sales by Country (2021-2026) & (K Units) Table 195. SAMEA Blood Coagulants Sales by Country (2027-2032) & (K Units) Table 196. SAMEA Blood Coagulants Sales Price by Country (2021-2026) & (US$/Unit) Table 197. SAMEA Blood Coagulants Sales Price by Country (2027-2032) & (US$/Unit) Table 198. Brazil Blood Coagulants Revenue (2021-2032) & (US$ Million) Table 199. Argentina Blood Coagulants Revenue (2021-2032) & (US$ Million) Table 200. Chile Blood Coagulants Revenue (2021-2032) & (US$ Million) Table 201. Colombia Blood Coagulants Revenue (2021-2032) & (US$ Million) Table 202. Peru Blood Coagulants Revenue (2021-2032) & (US$ Million) Table 203. Saudi Arabia Blood Coagulants Revenue (2021-2032) & (US$ Million) Table 204. Israel Blood Coagulants Revenue (2021-2032) & (US$ Million) Table 205. UAE Blood Coagulants Revenue (2021-2032) & (US$ Million) Table 206. Turkey Blood Coagulants Revenue (2021-2032) & (US$ Million) Table 207. Iran Blood Coagulants Revenue (2021-2032) & (US$ Million) Table 208. Egypt Blood Coagulants Revenue (2021-2032) & (US$ Million) Table 209. Key Raw Materials Table 210. Raw Materials Key Suppliers Table 211. Blood Coagulants Distributors List Table 212. Blood Coagulants Customers List Table 213. Research Programs/Design for This Report Table 214. Authors List of This Report Table 215. Secondary Sources Table 216. Primary Sources List of Figures Figure 1. Blood Coagulants Image Figure 2. Global Blood Coagulants Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Blood Coagulants Market Size Share 2021 VS 2025 VS 2032 Figure 4. Recombinant Coagulation Factor Image Figure 5. Plasma Coagulation Factor Image Figure 6. Global Blood Coagulants Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Blood Coagulants Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospital Image Figure 9. Pharmacy Image Figure 10. Other Image Figure 11. Global Blood Coagulants Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Blood Coagulants Revenue (2021-2032) & (US$ Million) Figure 13. Global Blood Coagulants Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Blood Coagulants Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Blood Coagulants Revenue Market Share by Region (2021-2032) Figure 16. Global Blood Coagulants Sales (2021-2032) & (K Units) Figure 17. Global Blood Coagulants Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 18. Global Blood Coagulants Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Blood Coagulants Sales YoY (2021-2032) & (K Units) Figure 20. Europe Blood Coagulants Sales YoY (2021-2032) & (K Units) Figure 21. China Blood Coagulants Sales YoY (2021-2032) & (K Units) Figure 22. Asia (Excluding China) Blood Coagulants Sales YoY (2021-2032) & (K Units) Figure 23. South America, Middle East and Africa Blood Coagulants Sales YoY (2021-2032) & (K Units) Figure 24. Global Blood Coagulants Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Blood Coagulants Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Blood Coagulants Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Blood Coagulants Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Blood Coagulants Revenue Market Share by Type (2021-2032) Figure 30. Global Blood Coagulants Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 31. Global Blood Coagulants Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Blood Coagulants Sales Market Share by Type (2021-2032) Figure 33. Global Blood Coagulants Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Blood Coagulants Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Blood Coagulants Revenue Market Share by Application (2021-2032) Figure 36. Global Blood Coagulants Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 37. Global Blood Coagulants Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Blood Coagulants Sales Market Share by Application (2021-2032) Figure 39. North America Blood Coagulants Revenue Share by Type (2021-2032) Figure 40. North America Blood Coagulants Sales Share by Type (2021-2032) Figure 41. North America Blood Coagulants Revenue Share by Application (2021-2032) Figure 42. North America Blood Coagulants Sales Share by Application (2021-2032) Figure 43. North America Blood Coagulants Revenue Share by Country (2021-2032) Figure 44. North America Blood Coagulants Sales Share by Country (2021-2032) Figure 45. Europe Blood Coagulants Revenue Share by Type (2021-2032) Figure 46. Europe Blood Coagulants Sales Share by Type (2021-2032) Figure 47. Europe Blood Coagulants Revenue Share by Application (2021-2032) Figure 48. Europe Blood Coagulants Sales Share by Application (2021-2032) Figure 49. Europe Blood Coagulants Revenue Share by Country (2021-2032) Figure 50. Europe Blood Coagulants Sales Share by Country (2021-2032) Figure 51. China Blood Coagulants Revenue Share by Type (2021-2032) Figure 52. China Blood Coagulants Sales Share by Type (2021-2032) Figure 53. China Blood Coagulants Revenue Share by Application (2021-2032) Figure 54. China Blood Coagulants Sales Share by Application (2021-2032) Figure 55. Asia Blood Coagulants Revenue Share by Type (2021-2032) Figure 56. Asia Blood Coagulants Sales Share by Type (2021-2032) Figure 57. Asia Blood Coagulants Revenue Share by Application (2021-2032) Figure 58. Asia Blood Coagulants Sales Share by Application (2021-2032) Figure 59. Asia Blood Coagulants Revenue Share by Country (2021-2032) Figure 60. Asia Blood Coagulants Sales Share by Country (2021-2032) Figure 61. SAMEA Blood Coagulants Revenue Share by Type (2021-2032) Figure 62. SAMEA Blood Coagulants Sales Share by Type (2021-2032) Figure 63. SAMEA Blood Coagulants Revenue Share by Application (2021-2032) Figure 64. SAMEA Blood Coagulants Sales Share by Application (2021-2032) Figure 65. SAMEA Blood Coagulants Revenue Share by Country (2021-2032) Figure 66. SAMEA Blood Coagulants Sales Share by Country (2021-2032) Figure 67. Blood Coagulants Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Blood Coagulants Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Recombinant Coagulation Factor
  • Plasma Coagulation Factor
Applications
  • Hospital
  • Pharmacy
  • Other
Companies covered
  • Takeda
  • Novo Nordisk
  • Pfizer
  • Bayer
  • SOBI
  • Octapharma
  • CSL

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Blood Coagulants Market by Type
  3. 1.2.1 Global Blood Coagulants Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Recombinant Coagulation Factor
  5. 1.2.3 Plasma Coagulation Factor
  6. 1.3 Blood Coagulants Market by Application
  7. 1.3.1 Global Blood Coagulants Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospital
  9. 1.3.3 Pharmacy
  10. 1.3.4 Other
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Blood Coagulants Market Dynamics
  1. 2.1 Blood Coagulants Industry Trends
  2. 2.2 Blood Coagulants Industry Drivers
  3. 2.3 Blood Coagulants Industry Opportunities and Challenges
  4. 2.4 Blood Coagulants Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Blood Coagulants Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Blood Coagulants Revenue by Region
  3. 3.2.1 Global Blood Coagulants Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Blood Coagulants Revenue by Region (2021-2026)
  5. 3.2.3 Global Blood Coagulants Revenue by Region (2027-2032)
  6. 3.2.4 Global Blood Coagulants Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Blood Coagulants Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Blood Coagulants Sales by Region
  9. 3.4.1 Global Blood Coagulants Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Blood Coagulants Sales by Region (2021-2026)
  11. 3.4.3 Global Blood Coagulants Sales by Region (2027-2032)
  12. 3.4.4 Global Blood Coagulants Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Blood Coagulants Revenue by Manufacturers
  2. 4.1.1 Global Blood Coagulants Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Blood Coagulants Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Blood Coagulants Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Blood Coagulants Sales by Manufacturers
  6. 4.2.1 Global Blood Coagulants Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Blood Coagulants Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Blood Coagulants Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Blood Coagulants Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Blood Coagulants Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Blood Coagulants Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Blood Coagulants Manufacturers, Product Type & Application
  13. 4.7 Global Blood Coagulants Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Blood Coagulants Market CR5 and HHI
  16. 4.8.2 2025 Blood Coagulants Tier 1, Tier 2, and Tier 3
5 Blood Coagulants Market by Type
  1. 5.1 Global Blood Coagulants Revenue by Type
  2. 5.1.1 Global Blood Coagulants Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Blood Coagulants Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Blood Coagulants Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Blood Coagulants Sales by Type
  6. 5.2.1 Global Blood Coagulants Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Blood Coagulants Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Blood Coagulants Sales Market Share by Type (2021-2032)
  9. 5.3 Global Blood Coagulants Price by Type
6 Blood Coagulants Market by Application
  1. 6.1 Global Blood Coagulants Revenue by Application
  2. 6.1.1 Global Blood Coagulants Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Blood Coagulants Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Blood Coagulants Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Blood Coagulants Sales by Application
  6. 6.2.1 Global Blood Coagulants Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Blood Coagulants Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Blood Coagulants Sales Market Share by Application (2021-2032)
  9. 6.3 Global Blood Coagulants Price by Application
7 Company Profiles
  1. 7.1 Takeda
  2. 7.1.1 Takeda Company Information
  3. 7.1.2 Takeda Business Overview
  4. 7.1.3 Takeda Blood Coagulants Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Takeda Blood Coagulants Product Portfolio
  6. 7.1.5 Takeda Recent Developments
  7. 7.2 Novo Nordisk
  8. 7.2.1 Novo Nordisk Company Information
  9. 7.2.2 Novo Nordisk Business Overview
  10. 7.2.3 Novo Nordisk Blood Coagulants Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Novo Nordisk Blood Coagulants Product Portfolio
  12. 7.2.5 Novo Nordisk Recent Developments
  13. 7.3 Pfizer
  14. 7.3.1 Pfizer Company Information
  15. 7.3.2 Pfizer Business Overview
  16. 7.3.3 Pfizer Blood Coagulants Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Pfizer Blood Coagulants Product Portfolio
  18. 7.3.5 Pfizer Recent Developments
  19. 7.4 Bayer
  20. 7.4.1 Bayer Company Information
  21. 7.4.2 Bayer Business Overview
  22. 7.4.3 Bayer Blood Coagulants Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Bayer Blood Coagulants Product Portfolio
  24. 7.4.5 Bayer Recent Developments
  25. 7.5 SOBI
  26. 7.5.1 SOBI Company Information
  27. 7.5.2 SOBI Business Overview
  28. 7.5.3 SOBI Blood Coagulants Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 SOBI Blood Coagulants Product Portfolio
  30. 7.5.5 SOBI Recent Developments
  31. 7.6 Octapharma
  32. 7.6.1 Octapharma Company Information
  33. 7.6.2 Octapharma Business Overview
  34. 7.6.3 Octapharma Blood Coagulants Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Octapharma Blood Coagulants Product Portfolio
  36. 7.6.5 Octapharma Recent Developments
  37. 7.7 CSL
  38. 7.7.1 CSL Company Information
  39. 7.7.2 CSL Business Overview
  40. 7.7.3 CSL Blood Coagulants Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 CSL Blood Coagulants Product Portfolio
  42. 7.7.5 CSL Recent Developments
8 North America
  1. 8.1 North America Blood Coagulants Market Size by Type
  2. 8.1.1 North America Blood Coagulants Revenue by Type (2021-2032)
  3. 8.1.2 North America Blood Coagulants Sales by Type (2021-2032)
  4. 8.1.3 North America Blood Coagulants Price by Type (2021-2032)
  5. 8.2 North America Blood Coagulants Market Size by Application
  6. 8.2.1 North America Blood Coagulants Revenue by Application (2021-2032)
  7. 8.2.2 North America Blood Coagulants Sales by Application (2021-2032)
  8. 8.2.3 North America Blood Coagulants Price by Application (2021-2032)
  9. 8.3 North America Blood Coagulants Market Size by Country
  10. 8.3.1 North America Blood Coagulants Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Blood Coagulants Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Blood Coagulants Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Blood Coagulants Market Size by Type
  2. 9.1.1 Europe Blood Coagulants Revenue by Type (2021-2032)
  3. 9.1.2 Europe Blood Coagulants Sales by Type (2021-2032)
  4. 9.1.3 Europe Blood Coagulants Price by Type (2021-2032)
  5. 9.2 Europe Blood Coagulants Market Size by Application
  6. 9.2.1 Europe Blood Coagulants Revenue by Application (2021-2032)
  7. 9.2.2 Europe Blood Coagulants Sales by Application (2021-2032)
  8. 9.2.3 Europe Blood Coagulants Price by Application (2021-2032)
  9. 9.3 Europe Blood Coagulants Market Size by Country
  10. 9.3.1 Europe Blood Coagulants Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Blood Coagulants Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Blood Coagulants Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
  18. 9.3.9 Nordic Countries
10 China
  1. 10.1 China Blood Coagulants Market Size by Type
  2. 10.1.1 China Blood Coagulants Revenue by Type (2021-2032)
  3. 10.1.2 China Blood Coagulants Sales by Type (2021-2032)
  4. 10.1.3 China Blood Coagulants Price by Type (2021-2032)
  5. 10.2 China Blood Coagulants Market Size by Application
  6. 10.2.1 China Blood Coagulants Revenue by Application (2021-2032)
  7. 10.2.2 China Blood Coagulants Sales by Application (2021-2032)
  8. 10.2.3 China Blood Coagulants Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Blood Coagulants Market Size by Type
  2. 11.1.1 Asia Blood Coagulants Revenue by Type (2021-2032)
  3. 11.1.2 Asia Blood Coagulants Sales by Type (2021-2032)
  4. 11.1.3 Asia Blood Coagulants Price by Type (2021-2032)
  5. 11.2 Asia Blood Coagulants Market Size by Application
  6. 11.2.1 Asia Blood Coagulants Revenue by Application (2021-2032)
  7. 11.2.2 Asia Blood Coagulants Sales by Application (2021-2032)
  8. 11.2.3 Asia Blood Coagulants Price by Application (2021-2032)
  9. 11.3 Asia Blood Coagulants Market Size by Country
  10. 11.3.1 Asia Blood Coagulants Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Blood Coagulants Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Blood Coagulants Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Blood Coagulants Market Size by Type
  2. 12.1.1 SAMEA Blood Coagulants Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Blood Coagulants Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Blood Coagulants Price by Type (2021-2032)
  5. 12.2 SAMEA Blood Coagulants Market Size by Application
  6. 12.2.1 SAMEA Blood Coagulants Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Blood Coagulants Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Blood Coagulants Price by Application (2021-2032)
  9. 12.3 SAMEA Blood Coagulants Market Size by Country
  10. 12.3.1 SAMEA Blood Coagulants Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Blood Coagulants Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Blood Coagulants Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Blood Coagulants Value Chain Analysis
  2. 13.1.1 Blood Coagulants Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Blood Coagulants Production Mode & Process
  6. 13.2 Blood Coagulants Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Blood Coagulants Distributors
  9. 13.2.3 Blood Coagulants Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst